BACE1 and Alzheimer disease: Results of those future studies may allow to draw definitive conclusions on the tolerability and molecular, neurophysiological, and behavioral effects of the BACE-1 inhibitor ER-901356 treatment on the present spectral EEG biomarkers in this popular mouse model of AD-like amyloid neuropathology.